Automation makes personalized medicine affordable

Users benefit from cooperation between family business and start-up

19-Jan-2026
Bürkert Fluid Control Systems

Felix Wollenhaupt (Green Elephant Biotech) and Hendrik Faustmann (Bürkert Fluid Control Systems) are pleased about the cooperation, which benefits not only Bürkert and Green Elephant Biotech, but above all the users.

It is not uncommon for the innovative strength of a start-up to be thwarted as soon as an investor steps in and imposes overly complex processes. In the cooperation between the family-owned company Bürkert Fluid Control Systems and Green Elephant Biotech (GEB), the specialists for sustainable cell culture and laboratory technology, a conscious effort was therefore made to prevent precisely this. This benefits not only both companies, but also the users. As a biotech expert for sustainable cell culture technology in the life sciences sector, the start-up is an innovative player in the biotechnology industry. This know-how and the corresponding networks are very helpful for the fluidics expert. The family-owned company, in turn, contributes many years of expertise in the planning and development of automated fluidics solutions. The cooperation also benefits from the regional proximity and the common native language. Felix Wollenhaupt, co-founder and Managing Director at GEB, explains: "Bürkert is attractive to us as a technology partner because the collaboration allows us to close the gaps in device development, fluid control, control technology and also the entire system integration."

Products for regenerative management

Various GEB products demonstrate the concrete benefits that users derive from the cooperation: Personalized medicine and laboratory consumables made from plant-based plastic. Personalized medicine can save lives, but is usually very expensive. This is due to the fact that the products are manufactured in individual batch sizes, yet entail a similarly high level of effort in terms of documentation and quality assurance as series production. Labor costs in particular lead to high product costs, sometimes in the six- to seven-digit euro range. Through automation, the innovative CellScrew cell culture system can save on personnel costs and produce personalized medicine sustainably and efficiently. This brings it within a price range that can be covered by health insurance companies. The partnership, which brings together expertise from the fields of fluidics automation and biotechnology, creates considerable added value for society. The same applies to the biotechnologists' plant-based plastic (PLA) products. Conventional laboratory consumables such as Petri dishes, pipette tips or reaction vessels are usually made of polystyrene, a plastic that is not biodegradable and therefore problematic to dispose of. This is where PLA alternatives can have an important influence on the sustainable management of companies. The product examples clearly show the economic benefits that can arise from cooperation between innovative start-ups and renowned family businesses with flexible structures. The fluidics experts are therefore open to further cooperation, for example in the food & beverage, new food, laboratory and renewable energy sectors.

Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.

Other news from the department business & finance

Most read news

More news from our other portals

So close that even
molecules turn red...

Something is happening in the life science industry ...

This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.

See the theme worlds for related content

Topic world Cell culture technology

Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.

3 whitepaper
View topic world
Topic world Cell culture technology

Topic world Cell culture technology

Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.

3 whitepaper